Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Heart Failure with Preserved Ejection Fraction (HFpEF)
90%
Ischemic Heart Failure
76%
Implantable Cardioverter-defibrillator
74%
Extended Follow-up
63%
Heart Failure
63%
All-cause Mortality
61%
National Cohort Study
54%
Patients with Heart Failure
53%
Hazard Ratio
49%
Reduced Ejection Fraction
49%
95% Confidence Interval
49%
Frailty
46%
Long-run Risk
35%
Cardioverter-defibrillator Implantation
35%
Atrial Fibrillation
34%
Long-term Rate
28%
Heart Failure Hospitalization
27%
Cardiovascular Mortality
26%
Mineralocorticoid Receptor Antagonists
23%
Sacubitril/valsartan
23%
Medicine and Dentistry
Congestive Heart Failure
84%
Implantable Automatic Defibrillator
63%
Atrial Fibrillation
46%
Hazard Ratio
46%
Cohort Analysis
42%
Heart Failure with Reduced Ejection Fraction
41%
Heart Muscle Ischemia
31%
Cardiovascular System
28%
Ejection Fraction
24%
Frailty
21%
Glomerular Filtration Rate
21%
Percutaneous Aortic Valve Replacement
21%
Autoimmune Disease
21%
Systolic Heart Failure
17%
Cardiovascular Risk
15%
Infective Endocarditis
15%
Median Follow Up
13%
Prevalence
13%
Malignant Neoplasm
12%
Frailty Index
12%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Atrial Fibrillation
45%
Heart Failure with Reduced Ejection Fraction
43%
Mineralocorticoid Antagonist
30%
Valsartan/Sacubitril
22%
Autoimmune Disease
21%
Heart Muscle Ischemia
21%
Cardiovascular Risk
15%
Beta Adrenergic Receptor Blocking Agent
14%
Pharmacotherapy
14%
Cerebrovascular Accident
13%
Antiplatelet
12%
Acute Heart Infarction
11%
Brain Ischemia
11%
Placebo
10%
Frailty
10%
Cohort Study
10%
All Cause Mortality
10%
Heart Ventricle Arrhythmia
10%
Randomized Clinical Trial
10%
